d

ASIRI HOSPITAL HOLDINGS PLC

PROVISIONAL ACCOUNTS FOR THE PERIOD ENDED
30TH SEPTEMBER 2023
Asiri Hospital Holdings PLC and Its Subsidiaries

STATEMENT OF PROFIT OR LOSS

For the Period Ended 30 September

GROUP COMPANY

30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22

Rs. Rs. Rs. Rs.
Un-audited Un-audited Un-audited Un-audited
Revenue 13,935,862,518 11,501,734,446 6,078,676,393 4,828,064,318
Cost of Services (7,458,404,059) (6,410,078,187) (3,041,396,158) (2,465,674,954)

Gross Profit 6,477,458,459 5,091,656,259 3,037,280,236 2,362,389,364

Other Income 125,749,459 124,498,748 61,974,997 66,217,191

Administrative Expenses (3,181,370,912) (2,505,413,197) (1,305,714,989) (1,054,645,481)
Selling and Distribution Expenses (366,826,184) (328,616,853) (192,522,520) (164,065,096)
Finance Costs (2,221,670,622) (2,106,955,967) (1,701,663,380) (1,660,048,913)
Finance Income 989,446,203 877,309,175 100,242,992 71,404,046
Profit/(Loss) Before Tax 1,822,786,403 1,152,478,165 (402,663) (378,748,889)
Tax Expense (586,110,574) (402,562,862) (68,500,000) (49,686,714)
Profit/(Loss) for the Period 1,236,675,829 749,915,303 (68,902,663) (428,435,603)

Attributable to:
Equity Holders of the Parent Company 1,093,884,727 645,945,375
Non-Controlling Interest 142,791,102 103,969,928
1,236,675,829 749,915,303

Earnings Per Share- Basic 0.96 0.57 (0.06) (0.38)

Dividend Per Share- Ordinary Shares 0.00 0.00 0.00 0.00

-1-
Asiri Hospital Holdings PLC and Its Subsidiaries
STATEMENT OF COMPREHENSIVE INCOME
For the Period Ended 30 September

Group Company
30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22
Rs. Rs. Rs. Rs.
Un-audited Un-audited Un-audited Un-audited
Profit/(Loss) for the Period 1,236,675,829 749,915,303 (68,902,663) (428,435,603)

Other Comprehensive Income not to be reclassified to Statement of Profit or Loss in

subsequent periods (net of tax):
Net (Loss)/Gain on Equity Instrument Designated at FVOCI 129,033,005 (78,835,575) (11,097,815) (2,874,446)

Net Other Comprehensive Income not to be reclassified to Statement of Profit or Loss in

subsequent periods (net of tax): 129,033,005 (78,835,575) (11,097,815) (2,874,446)

Other Comprehensive Income/(Loss) for the Period, Net of Tax 129,033,005 (78,835,575) (11,097,815) (2,874,446)

Total Comprehensive Income/(Loss) for the Period, Net of Tax 1,365,708,834 671,079,728 (80,000,478) (431,310,049)

Total Comprehensive Income Attributable to:

Equity Holders of the Parent Company 1,195,851,093 581,782,048
Non-Controlling Interest 169,857,741 89,297,680
1,365,708,834 671,079,728

-2-
Asiri Hospital Holdings PLC and Its Subsidiaries
STATEMENT OF PROFIT OR LOSS
For the Three Months Ended 30 September

GROUP COMPANY
30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22
Rs. Rs. Rs. Rs.
Un-audited Un-audited Un-audited Un-audited
Revenue 6,996,778,656 6,077,043,368 3,079,461,697 2,586,890,791
Cost of Services (3,769,374,960) (3,341,493,635)
- (1,543,182,773) (1,304,675,101)
Gross Profit 3,227,403,696 2,735,549,733 1,536,278,924 1,282,215,690

Other Income 57,052,257 45,607,415 29,822,267 28,159,678

Administrative Expenses (1,626,188,642) (1,312,549,394) (664,045,325) (543,721,246)
Selling and Distribution Expenses (187,575,658) (162,071,764) (99,209,859) (83,863,029)
Finance Costs (978,448,483) (1,345,748,014) (765,744,076) (1,005,960,431)
Finance Income 403,176,673 600,965,931 47,631,711 36,467,122
Profit Before Tax 895,419,843 561,753,907
- 84,733,642 (286,702,216)
Tax Expense (283,716,354) (224,070,602)
- (33,500,000) (26,250,465)
Profit for the Period 611,703,489 337,683,305 51,233,642 (312,952,681)

Attributable to:
Equity Holders of the Parent Company 548,933,429 276,531,814
Non-Controlling Interests 62,770,060 61,151,491
611,703,489 337,683,305

Earnings Per Share - Basic 0.48 0.24 0.05 -0.28

Dividend Per Share - Ordinary Shares 0.00 0.00 0.00 1.30

-3-
Asiri Hospital Holdings PLC and Its Subsidiaries

STATEMENT OF COMPREHENSIVE INCOME

For the Three Months Ended 30 September

Group Company
30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22
Rs. Rs. Rs. Rs.
Un-audited Un-audited Un-audited Un-audited

Profit for the Period 611,703,489 337,683,305 51,233,642 (312,952,681)

Other Comprehensive Income not to be reclassified to Statement of Profit or Loss in subsequent

periods (net of tax):
Net Gain on Equity Instrument Designated at FVOCI 110,078,206 51,227,443 - 6,418,602
Net Other Comprehensive Income not to be reclassified to Statement of Profit or Loss in
subsequent periods (net of tax): 110,078,206 51,227,443 - 6,418,602

Other Comprehensive Income/(Loss) for the Period, Net of Tax 110,078,206 51,227,443 - 6,418,602

Total Comprehensive Income/(Loss) for the Period, Net of Tax 721,781,695 388,910,748 51,233,642 (306,534,079)

Attributable to:
Equity Holders of the Parent Company 637,754,440 319,104,202
Non-Controlling Interests 84,027,255 69,806,546
721,781,695 388,910,748

-4-
Asiri Hospital Holdings PLC and Its Subsidiaries
STATEMENT OF FINANCIAL POSITION

GROUP COMPANY GROUP COMPANY

31-Mar-23 31-Mar-23 30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22
Rs. Rs. Rs. Rs. Rs. Rs.
Audited Audited ASSETS Un-audited Un-audited Un-audited Un-audited
Non-current Assets
33,205,836,331 14,918,707,716 Property, Plant and Equipment 32,899,928,003 29,676,404,238 14,860,908,684 13,996,944,368
1,175,011,170 1,000,620,616 Right of Use Assets 1,176,307,792 1,192,995,874 978,315,177 1,018,304,834
609,654,071 - Goodwill 609,654,071 609,654,071 - -
- 12,341,731,252 Investment in Subsidiaries - - 12,345,112,833 12,341,417,365
5,354,886,724 - Loans granted to Related Parties 3,886,978,634 - - -
61,506,062 35,524,062 Other Non Current Assets 67,027,560 63,387,176 38,682,562 37,405,176
351,419,210 99,929,600 Other Non-Current Financial Assets 434,404,951 337,173,066 30,000,000 96,325,554
40,758,313,568 28,396,513,246 39,074,301,011 31,879,614,425 28,253,019,256 27,490,397,297

Current Assets
1,232,954,509 470,774,491 Inventories 1,268,746,099 1,354,848,615 541,877,970 486,618,883
802,221,721 801,408,927 Trade and Other Receivables 1,040,233,884 749,510,292 903,151,785 739,118,578
5,456,408,364 328,265,517 Loans Granted to Related Parties 6,982,714,235 8,456,896,487 350,920,489 333,252
482,503,552 129,522,783 Other Current Assets 576,756,557 648,664,225 210,660,669 210,817,950
1,552,653,341 551,970,991 Cash and Cash Equivalents 1,791,858,659 1,849,060,133 691,767,592 366,864,971
9,526,741,487 2,281,942,708 11,660,309,435 13,058,979,753 2,698,378,505 1,803,753,633
50,285,055,054 30,678,455,954 Total Assets 50,734,610,446 44,938,594,178 30,951,397,761 29,294,150,930

EQUITY AND LIABILITIES

Capital and Reserves
4,748,108,334 4,748,108,334 Stated Capital 4,748,108,334 4,748,108,334 4,748,108,334 4,748,108,334
8,368,528,850 4,069,022,149 Other Components of Equity 8,471,171,580 6,851,124,703 4,057,924,334 4,072,768,217
4,600,553,861 854,660,646 Retained Earnings 5,694,438,588 3,636,018,744 785,757,983 1,345,179,201
17,717,191,046 9,671,791,129 Share Holders' Fund 18,913,718,503 15,235,251,781 9,591,790,651 10,166,055,752
1,458,293,985 - Non-Controlling Interests 1,624,093,780 1,258,665,531 - -
19,175,485,031 9,671,791,129 Total Equity 20,537,812,283 16,493,917,312 9,591,790,651 10,166,055,752

Non-current Liabilities
4,715,755,743 5,220,707,512 Interest Bearing Loans and Borrowings 4,083,596,178 5,538,592,521 5,938,128,918 5,679,786,506
4,573,108,327 2,212,227,860 Deferred Tax Liabilities 4,649,786,380 2,063,719,845 2,277,727,856 947,589,763
582,583,970 223,590,779 Employee Benefit Liability 627,984,406 730,035,832 240,791,943 296,593,200
9,871,448,040 7,656,526,151 9,361,366,964 8,332,348,198 8,456,648,717 6,923,969,469

Current Liabilities
3,653,043,000 1,747,169,469 Trade and Other Payables 4,569,671,746 3,055,008,789 1,946,676,527 1,367,103,909
75,685,657 61,999,952 Dividend Payable 75,535,521 58,747,626 61,888,068 48,264,284
12,808,752,047 8,754,221,822 Interest Bearing Loans and Borrowings 11,420,501,089 12,246,022,018 8,077,503,362 7,846,727,089
521,814,063 7,140,625 Income Tax Payable 575,119,853 227,602,359 10,140,626 38,138,798
4,178,827,217 2,779,606,807 Bank Overdraft 4,194,602,991 4,524,947,877 2,806,749,810 2,903,891,629
21,238,121,983 13,350,138,674 20,835,431,200 20,112,328,669 12,902,958,393 12,204,125,709
50,285,055,054 30,678,455,954 Total Equity and Liabilities 50,734,610,446 44,938,594,178 30,951,397,761 29,294,150,930

15.58 8.50 Net Assets Per Share 16.63 13.39 8.43 8.94

The above figures are provisional & subject to audit. 1227088.5 222,873,021
It is certified that the Financial Statements have been prepared in accordance with the requirements of the Companies Act No.7 of 2007.

- Sgd -
……………………………………..
Ajith Karunarathne
Director Finance

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.
Signed for and on behalf of the Board.

- Sgd- - Sgd-
…………………………………….. ……………………………….
Ashok Pathirage Dr. Manjula Karunaratne
Chairman / Managing Director Director/Chief Executive Officer

10th November 2023

Colombo

-5-
Asiri Hospital Holdings PLC and Its Subsidiaries

STATEMENT OF CHANGES IN EQUITY

For the Period Ended 30 September

GROUP Equity Attributable to Equity Holders of the Parent

Fair Value Reserve
Revaluation Reserve on Retained Foreign Currency Minority
Stated Capital of Financial Assets at Total
Reserve Consolidation Earnings Translation Reserve Interest
FVOCI

Rs. Rs. Rs. Rs. Rs. Rs. Rs. Rs.

Balance as at 01 April 2022 4,748,108,334 8,022,444,831 (920,572,167) 2,990,073,369 (183,580,613) (3,004,019) 1,169,367,850 15,822,837,584

Profit for the Period - - - 645,945,375 - - 103,969,928 749,915,303

Other Comprehensive Income - - - - (64,163,328) - (14,672,247) (78,835,575)
Total Comprehensive Income - - - 645,945,375 (64,163,328) - 89,297,681 671,079,728
Acquisition of Non-Controlling Interest - - - - - - - -

Balance as at 30 September 2022 4,748,108,334 8,022,444,831 (920,572,167) 3,636,018,744 (247,743,941) (3,004,019) 1,258,665,531 16,493,917,312

Balance as at 01 April 2023 4,748,108,334 9,525,855,899 (920,520,363) 4,600,553,861 (233,532,076) (3,274,609) 1,458,293,985 19,175,485,031

Profit for the Period - - - 1,093,884,727 - - 142,791,102 1,236,675,829

Other Comprehensive Income - - - - 101,966,366 - 27,066,639 129,033,005
Total Comprehensive Income - - - 1,093,884,727 101,966,366 - 169,857,741 1,365,708,834
Equity Investments at FVOCI reclassified to Retained Earnings (45,058,239) 45,058,239 -
Acquisition of Non-Controlling Interest - - 676,364 - - - (4,057,946) (3,381,582)
Balance as at 30 September 2023 4,748,108,334 9,525,855,899 (919,843,999) 5,694,438,588 (131,565,710) (3,274,609) 1,624,093,780 20,537,812,283

COMPANY
Fair Value Reserve
Retained
Stated Capital Revaluation Reserve of Financial Assets at Total
Earnings
FVOCI

Rs. Rs. Rs. Rs. Rs.

Balance as at 01 April 2022 - 4,748,108,334 - 4,112,354,091 - (36,711,427) 1,773,614,804 10,597,365,801

Profit for the Period - - - (428,435,603) (428,435,603)
Other Comprehensive Income - - (2,874,446) - (2,874,446)
Total Comprehensive Income -- -- (2,874,446) (428,435,603) (431,310,049)
-
Balance as at 30 September 2022 4,748,108,334 4,112,354,091 (39,585,873) 1,345,179,201 10,166,055,752

Balance as at 01 April 2023 - 4,748,108,334 - 4,102,982,572 - (33,960,423) 854,660,646 9,671,791,129

Loss for the Period - - - (68,902,663) (68,902,663)
Other Comprehensive Income - - (11,097,815) - (11,097,815)
Total Comprehensive Income - - (11,097,815) (68,902,663) (80,000,479)
Equity Investments at FVOCI reclassified to Retained Earnings 45,058,239 (45,058,239) -

Balance as at 30 September 2023 4,748,108,334 4,102,982,572 (45,058,238) 785,757,983 9,591,790,651

-6-
Asiri Hospital Holdings PLC and Its Subsidiaries

STATEMENT OF CASH FLOWS

For the Period Ended 30 September

GROUP COMPANY
30-Sep-23 30-Sep-22 30-Sep-23 30-Sep-22
Rs. Rs. Rs. Rs.
Un-audited Un-audited Un-audited Un-audited

Cash Flows from/(used in) Operating Activities

Profit/(Loss) Before Tax Expense 1,822,786,403 1,152,478,165 (402,663) (378,748,889)

Adjustments for
Depreciation 847,118,719 770,449,287 371,341,768 351,999,359
Amortization of Leasehold Assets 80,848,101 72,612,532 58,255,271 54,880,948
Loss/(Profit) on Disposal of Property, Plant and Equipment 1,610,848 1,850,670 1,123,580 833,428
Net loss on share disposal 1,258,709 1,258,709 -
Script Dividend Income (16,354,500) (3,569,980) -
Provision for Bad and Doubtful Debts 1,371,411 3,330,302 6,542,935 3,392,560
Provision for Retirement Gratuity 87,983,167 72,900,561 39,141,450 34,440,200
Unrealized Foreign Currency Exchange Gain 3,927,880 15,414.00 29,841 (935,111)
Finance Costs 2,221,670,622 2,106,955,967 1,701,663,380 1,660,048,913
Income from Investments (989,446,203) (877,309,175) (100,242,992) (71,404,046)
Operating Profit Before Working Capital Changes 4,062,775,157 3,303,283,724 2,075,141,298 1,654,507,361

Changes in Working Capital

(Increase)/Decrease in Inventories (35,791,590) (354,628,425) (71,103,479) (187,065,849)
(Increase)/ Decrease in Other Current Assets (94,253,005) (142,098,988) (84,296,386) (64,308,404)
Decrease/(Increase) in Trade and Other Receivables (239,383,574) (45,095,048) (97,345,198) (275,307,911)
Increase in Trade and Other Payables 916,628,746 1,116,746,539 197,192,209 290,822,545
Cash Generated from Operations 4,609,975,735 3,878,207,802 2,019,588,444 1,418,647,742

Income Tax paid (457,381,956) (489,803,015) - (219,721,855)

Finance Costs paid (1,846,098,502) (1,831,132,355) (977,860,385) (1,271,389,463)
Defined Benefit Plan Costs paid (42,400,296) (41,983,048) (21,752,596) (14,595,806)
Net Cash from/(used in) Operating Activities 2,264,094,982 1,515,289,384 1,019,975,463 (87,059,382)

Cash Flows from/(used in) Investing Activities

Acquisition of Property, Plant and Equipment (550,059,211) (686,541,452) (317,978,733) (243,700,364)

Increase in Interest in Subsidiaries - - (3,381,582) -
(Increase)/ Decrease in Loans Granted to Related Parties 82,713,006 (3,584,215,904) 5,000,000 702,185,685
Proceed from/(repayment of) Loans Obtained From Related Parties (125,000,000) 142,905,505 150,094,495 (3,279,054,411)
Dividend Received - - - 744,959,212
Cash received from Sale of shares 61,143,055 61,143,055 -
Proceeds from Disposal of Property, Plant and Equipment 7,266,771 1,768,578 3,312,201 936,338
Income From Investments 187,002,415 193,990,977 61,647,426 85,557,162
Net Cash used in Investing Activities (336,933,964) (3,932,092,297) (40,163,138) (1,989,116,376)

Cash Flows from/(used in) Financing Activities

Dividends Paid (150,136) (1,450,885,075) (111,884) (1,352,287,513)

Acquisition of Non Controlling Interests (3,381,582) - - -
Net Proceeds/(Net Repayments) from External Borrowings (1,611,132,758) 3,511,563,547 (806,982,768) 2,947,174,029
Repayment of Lease Obligations (89,066,997) (112,524,322) (60,064,077) (82,764,334)
Net Cash from/(used in) Financing Activities (1,703,731,473) 1,948,154,150 (867,158,729) 1,512,122,182

Net Increase/(Decrease) in Cash and Cash Equivalents 223,429,545 (468,648,762) 112,653,596 (564,053,577)

Cash and Cash Equivalents at the Beginning of the Year (2,626,173,877) (2,207,238,982) (2,227,635,816) (1,972,973,083)
Cash and Cash Equivalents at the End of the Year (2,402,744,332) (2,675,887,744) (2,114,982,218) (2,537,026,659)

Analysis of Cash and Cash Equivalents

Favourable Balances
Cash in Hand and at Bank 673,709,741 397,591,967 239,585,507 30,527,626
Short Term Investments 1,118,148,919 1,451,468,166 452,182,084 336,337,344
Unfavourable Balances
Bank Overdrafts (4,194,602,991) (4,524,947,877) (2,806,749,810) (2,903,891,629)
Cash and Cash Equivalents (2,402,744,332) (2,675,887,744) (2,114,982,218) (2,537,026,659)

-7-
Asiri Hospital Holdings PLC and Its Subsidiaries
NOTES TO THE INTERIM FINANCIAL STATEMENTS
For the Period Ended 30 September 2023

1. Corporate Information
1.1 General
Asiri Hospital Holdings PLC (“Company”) is a public limited liability Company, incorporated and domiciled in Sri Lanka and listed on the Colombo
Stock Exchange. The registered office and principal place of business is located at No. 181, Kirula Road, Colombo 5.

1.2 Date of Authorisation for Issue

The Interim Condensed Financial Statements of the Group and the Company for the period ended 30 September 2023 were authorised for issue by the
Board of Directors on 10th November 2023.

2. Basis of Preparation
The Interim Condensed Financial Statements have been prepared in accordance with Sri Lanka Accounting Standard - LKAS 34 Interim Financial
Reporting. These interim condensed financial statements should be read in conjunction with the annual financial statements for the year ended 31 March
2023. These financial statements provide the information as required in terms of Rule 7.4 of the Colombo Stock Exchange.

3. Accounting Policies
The same accounting policies and methods of computation as stated in the annual financial statements for the year ended 31 March 2023 are followed in
the preparation of these Interim Condensed Financial Statements.

4. Other Information

4.1 Loans Granted to Related Parties

Group

This includes loans granted to Softlogic Holdings PLC, Softlogic Brands (Pvt) Ltd ,Softlogic Super market (Pvt) Ltd Softlogic Retail (Pvt) Ltd ,Softlogic
Mobile Distribution (Pvt) Ltd and interest receivable thereon. The interest is charged at prevailing market interest rates for these loans.
Company
This includes loans granted to Softlogic Brands (Pvt) Ltd ,Softlogic Super Market (Pvt) Ltd and interest receivable thereon. The interest is charged at
prevailing market interest rates for these loans.

4.2 Contingent Liabilities

A dispute has arisen with the Department of Inland Revenue with regard to the applicability of the income tax exemption for the years of assessment
2005/06 to 2014/15, in terms of the agreement entered between Asiri Surgical Hospital PLC and the Board of Investment of Sri Lanka (BOI) in year
2000. With respect to the same we have received written notifications from the Tax Appeal Commission so far for the years of assessments from 2005/06
to 2013/14 and the company is assessing the provisioning requirement based on the applicable tax laws during that period. We are also in the process of
initiating Legal action against these assessments in the Court of Appeal.
We also have a case in the Court of Appeal in CA (Writ) 386/ 2016 preventing the recoverability of tax for the same mater and this will be coming up for
argument in Feb 2024, Since there is a litigation, in accordance with Paragraph 92 of LKAS 37, we are unable to provide further information on this and
associated risks, in order not to impair the outcome and/or prejudice the Company’s position in this matter Other than above, there are no significant
changes in the nature of the contingent liabilities and contingent assets which were disclosed in the Annual Report for the year ended 31 March 2023.

4.3 Capital Expenditure Commitments

There were no material commitments outstanding as at 30 September 2023 for future capital expenditure except for below;
Rs.22,330,617 contracted with suppliers for the construction of Asiri Hospital Kandy (Rs.3,838,276 as at 30 September 2022).

4.4 Comparative Information

Where necessary comparative figures have been reclassified to conform with the current year's presentation.
4.5 Events Occurring After the Reporting Period
There were no material events that occurred after the reporting date that require adjustments or disclosure to the Financial Statements.

-6-
Asiri Hospital Holdings PLC and Its Subsidiaries
INVESTOR INFORMATION
Market Value of Shares
The market value of an ordinary share of Asiri Hospital Holdings PLC is as follows:
Quarter to Quarter to
30-Sep-23 30-Sep-22
Highest Price per Share (Rs.) 28.60 35.00
Lowest Price per Share (Rs.) 23.00 26.00
Last Traded Price per Share (Rs.) 28.50 26.30

No of Shares Representing Stated Capital As at As at

30-Sep-23 30-Sep-22
No of Ordinary Shares 1,137,533,596 1,137,533,596
* Earnings and net assets per share are based on 1,137,533,596 shares in issue as at 30 September 2023.

Statement of Shareholding of Directors As at As at

Name of Director 30-Sep-23 30-Sep-22
Mr. A. K. Pathirage 371,664 371,664
Dr. K. M. P. Karunaratne 9,074 9,074
Dr. S. Selliah - -
Mr. G. L. H. Premaratne - -
Mr. H K Kaimal - -
Mr. Vishal Bali - -
Mr. A. N. Thadani - -
Mr. S. Ahangama - -

Major Shareholdings As at % As at %
Twenty Largest Shareholders 30-Sep-23 30-Sep-22

Softlogic Holdings Plc 627,025,050 55.12 626,054,757 55.04

Merrill Lynch Pierce Fenner & Smith-Tpg Growth Iii Sf Pte Ltd 328,258,328 28.86 328,258,328 28.86
Bbh-Tundra Sustainable Frontier Fund 30,000,000 2.64 30,000,000 2.64
Mr. Chaminda Dilantha Weerasinghe (Deceased) 9,375,000 0.82 9,375,000 0.82
Softlogic Life Insurance Plc-A/C No. 04 (Participating Fund) 9,000,000 0.79 9,000,000 0.79
Sri Lanka Insurance Corporation Ltd-Life Fund 7,851,792 0.69 7,851,792 0.69
Mr. Pujitha Punsiri Subasinghe 7,436,922 0.65 7,383,566 0.65
Softlogic Life Insurance Plc-A/C No. 05 (Non-Participating Fund) 5,956,877 0.52 5,956,877 0.52
Employees Trust Fund Board 4,245,693 0.37 4,245,693 0.37
Dr. Welagedara Mudiyanselage Swarnamali Welagedara 3,375,000 0.30 3,375,000 0.30
Mr. Ahamed Umar Maniku 3,219,350 0.28 3,219,350 0.28
Sri Lanka Insurance Corporation Ltd-General Fund 2,807,417 0.25 2,807,417 0.25
Mr. Hewa Komanage Jayantha Dharmadasa 2,788,920 0.25 2,788,920 0.25
Dr. Luhubanduwaduge Don Abo Claudius Luvis 2,741,720 0.24 2,741,720 0.24
Mr. Mohamed Faizer Hashim 2,087,160 0.18 2,086,160 0.18
Miss Theja Thushari Weerasinghe 1,746,630 0.15 1,746,630 0.15
Mr. Uditha Harilal Palihakkara 1,198,425 0.11 - -
Mr. Gajath Chrysantha Goonetilleke 1,133,260 0.10 1,133,260 0.10
Mrs. Yogeswari Wijayaratnam 1,074,010 0.09 1,074,010 0.09
CBHK S/A Platinum Broking Company Limited 1,068,241 0.09 1,168,881 0.10
MR. Ajith Harindra Weerasuriya - - 1,498,779 0.13
1,052,389,795 92.52 1,051,766,140 92.46
Shares held by the Balance Shareholdings 85,143,801 7.48 85,767,456 7.54
Total Issued Shares 1,137,533,596 100.00 1,137,533,596 100.00

Public Shareholding 166,912,603 14.67 167,882,896 14.76

Total Number of Public Shareholders 5,710 5,642
The Float- adjusted market capitalization as at 30th September 2023 is Rs. 4,755,971,088.20 and the Company is in compliance with option 3 of the
Listing Rules 7.13.1 (a) which requires 7.5% minimum public holding percentage and 500 minimum public shareholders.

-7-
Asiri Hospital Holdings PLC and Its Subsidiaries
CORPORATE INFORMATION

Name of the Company Remuneration Committee Auditors

Asiri Hospital Holdings PLC Chairman Messrs. Ernst & Young
Mr. G. L. H. Premaratne (Chartered Accountants)
Registered Office Independent Non-Executive Director # 201, De Saram Place,
# 181, Kirula Road, Colombo 05, Colombo 10.
Sri Lanka. Committee Members
Dr. S. Selliah Secretaries
Office & Administrative Independent Non-Executive Director Messrs. Softlogic Corporate Services (Pvt) Ltd
Complex # 14, De Fonseka Place, Colombo 5.
Asiri Surgical Hospital PLC Frequency of Meetings
# 21, Kirimandala Mawatha, Committee meets once a year Stock Code
Colombo 05, Sri Lanka. ASIR.N0000
Telephone: 011 4524400 Related Party Transactions Review Committee
Email: info@[Link] Chairman Bankers
Web: [Link] Mr. Sudarshan Ahangama Commercial Bank of Ceylon PLC
Independent Non-Executive Director Sampath Bank PLC
Company Registration Number Nations Trust Bank PLC
PQ204 Committee Members Hatton National Bank PLC
Mr. G. L. H. Premaratne Cargills Bank Limited
Legal Form Independent Non-Executive Director Bank of Ceylon PLC
A quoted public company incorporated in Sri Lanka on 29 September Mr. H K Kaimal National Development Bank PLC
1980, under the Companies Act No.17 of 1982, with limited [Link]- Non Independent Non-Executive Director Seylan Bank PLC
registered on 30 September 2008 under the Companies Act No. 07 of DFCC Bank PLC
2007.
Frequency of Meetings
Stock Exchange Listing Committee meets at least once a quarter
The Ordinary Shares of the Company have been listed with the Colombo
Stock Exchange since June 1986.
Subsidiary Companies
Board of Directors Central Hospital Ltd
Mr. A. K. Pathirage - Chairman/Managing Director # 114, Norris Canal Road, Colombo 10.
Dr. K. M. P. Karunaratne-Group Chief Executive Officer
Dr. S. Selliah - Deputy Chairman Asiri Central Hospitals Ltd
Mr. H K Kaimal # 114, Norris Canal Road, Colombo 10.

Mr. G. L. H. Premaratne Asiri Surgical Hospital PLC

Mr.V. Bali # 21, Kirimandala Mawatha, Colombo 5.
Mr. A. N. Thadani
Mr. S. Ahangama Asiri Diagnostics Services (Pvt) Ltd
# 181, Kirula Road, Colombo 05.

Audit Committee Asiri Hospital Matara (Pvt) Ltd

Chairman # 26, Esplanade Road, Uyanwatte,
Mr. S. Ahangama Matara.
Independent Non-Executive Director
Asiri Laboratories (Pvt) Ltd
Committee Members # 181, Kirula Road, Colombo 5.
Mr. G. L. H. Premaratne
Independent Non-Executive Director Asiri Hospital Galle (Pvt) Ltd
# 10, Wackwella Road, Galle.
Mr. H K Kaimal
Non Independent Non-Executive Director Asiri AOI Cancer Centre (Pvt) Ltd
# 21, Kirimandala Mawatha, Colombo 5.

Frequency of Meetings Asiri Port City Hospital (Pvt) Ltd.

Committee meets quarterly # 14, De Fonseka Place, Colombo 5.

Asiri Academy of Health Sciences (Pvt) Ltd.

# 181, Kirula Road, Colombo 5.

Asiri Diagnostics Services (Asia) Pte Limited

# 8, Temasek Boulevard, # 35-03 Suntec Tower 3.
Singapore.

-8-